( SEVAMED 2001)

(Diagnosis, Diagnostics, Immunodiagnosis, Immunodiagnostics, Pathogenesis, Vaccines & Drugs)

Click here for Abstract

Back To Content Page

 1326.      Agrawal VK; Sharma RC; Chakraborty PK Malaria control amongst troops involved in counter insurgency operation in resistant plasmodium falciparum areas. Medical Journal Armed Forces India 1998 Apr; 54(2): 105-6

 1327.      Alecrim WD.  Espinosa FE.  Alecrim MG. Plasmodium falciparum infection in the pregnant patient. [Review] [77 refs] Infectious Disease Clinics of North America.  14(1):83-95, viii-ix, 2000  Mar.

 1328.      Basco LK.  Ringwald P. Molecular epidemiology of malaria in Yaounde, Cameroon. VI. Sequence variations in the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene and in vitro resistance to  pyrimethamine and cycloguanil. American Journal of Tropical Medicine & Hygiene.  62(2):271-6, 2000 Feb.

 1329.      Biswas S.  Roy A. Serology for malaria diagnosis in children. Journal of Communicable Diseases.  30(4):297-300, 1998 Dec.

 1330.      Bodeker G.  Willcox M. The first international meeting of the Research Initiative on Traditional Antimalarial Methods (RITAM). Journal of Alternative & Complementary Medicine.  6(2):195-207, 2000 Apr.

 1331.      Bojang KA.  Obaro S.  Morison LA.  Greenwood BM. A prospective evaluation of a clinical algorithm for the diagnosis of malaria in Gambian children.  Tropical Medicine & International Health.  5(4):231-6, 2000 Apr.

 1332.      Dias RS.  Freitas AC.  Barreiro EJ.  Goins DK.  Nanayakkara D.  McChesney JD. Synthesis and biological activity of new potential antimalarial: 1H-pyrazolo[3,4-b]pyridine derivatives. Bollettino Chimico Farmaceutico.  139(1):14-20, 2000 Jan-Feb.

 1333.      Dobbie M.  Crawley J.  Waruiru C.  Marsh K.  Surtees R.Cerebrospinal fluid studies in children with cerebral malaria: an excitotoxic mechanism?. American Journal of Tropical Medicine & Hygiene.  62(2):284-90, 2000 Feb.

 1334.      Garner P.  Gulmezoglu AM. Prevention versus treatment for malaria in pregnant women. [Review] [19 refs] Cochrane Database of Systematic Reviews [computer file].  (2):CD000169,  2000.

 1335.      Gosi P.  Khusmith S.  Looareesuwan S.  Sitachamroom U.  Glanarongran R. Buchachart K.  Walsh DS. Complicated malaria is associated with differential elevations in serum levels of interleukins 10, 12, and 15.  Southeast Asian Journal of Tropical Medicine & Public Health.  30(3):412-7, 1999 Sep.

 1336.      Graves P.  Gelband H. Vaccines for preventing malaria. [Review] [25 refs] Cochrane Database of Systematic Reviews [computer file].  (2):CD000129,  2000.

 1337.      Gurunathan S.  Klinman DM.  Seder RA. DNA vaccines: immunology, application, and optimization*. [Review] [244 refs] Annual Review of Immunology.  18:927-74, 2000.

 1338.      Hanscheid T. Diagnosis of malaria: a review of alternatives to conventional microscopy. [Review] [77 refs] Clinical & Laboratory Haematology.  21(4):235-45, 1999 Aug.

 1339.      Hutagalung R.  Wilairatana P.  Looareesuwan S.  Brittenham GM.  Gordeuk VR. Influence of hemoglobin E trait on the antimalarial effect of artemisinin  derivatives.  Journal of Infectious Diseases.  181(4):1513-6, 2000 Apr.

 1340.      Kulkarni AV.  Kasturi L.  Amin A.  Mashankar V. Therapy and drug resistance in malaria. Indian Journal of Pediatrics.  67(1):33-5, 2000 Jan.

 1341.      Kwiatkowski D. Genetic dissection of the molecular pathogenesis of severe infection. [Review] [61 refs] Intensive Care Medicine.  26 Suppl 1:S89-97, 2000.

 1342.      Le TP.  Coonan KM.  Hedstrom RC.  Charoenvit Y.  Sedegah M.  Epstein JE.  Kumar S.  Wang R.  Doolan DL.  Maguire JD.  Parker SE.  Hobart P.  Norman J.  Hoffman SL. Safety, tolerability and humoral immune responses after intramuscular administration of a malaria DNA vaccine to healthy adult volunteers. Vaccine.  18(18):1893-901, 2000 Mar 17.

 1343.      Lees CM.  Davies S.  Dezateux C. Neonatal screening for sickle cell disease. [Review] [0 refs]Cochrane Database of Systematic Reviews [computer file].  (2):CD001913, 2000.

 1344.      Lell B.  Faucher JF.  Missinou MA.  Borrmann S.  Dangelmaier O.  Horton J. Kremsner PG. Malaria chemoprophylaxis with tafenoquine: a randomised study. Lancet.  355(9220):2041-5, 2000 Jun 10.

 1345.      Menendez C.  Ordi J.  Ismail MR.  Ventura PJ.  Aponte JJ.  Kahigwa E. Font F.  Alonso PL. The impact of placental malaria on gestational age and birth weight. Journal of Infectious Diseases.  181(5):1740-5, 2000 May.

 1346.      Meremikwu M.  Logan K.  Garner P. Antipyretic measures for treating fever in malaria. [Review] [3 refs] Cochrane Database of Systematic Reviews [computer file].  (2):CD002151, 2000.

 1347.      Nandi B A clinical study of falciparum malaria - 302 cases. Medical Journal Armed Forces India 1998 Jan; 54(1): 9-12

 1348.      Parra M.  Hui G.  Johnson AH.  Berzofsky JA.  Roberts T.  Quakyi IA. Taylor DW. Characterization of conserved T- and B-cell epitopes in Plasmodium falciparum major merozoite surface protein 1.  Infection & Immunity.  68(5):2685-91, 2000 May.

 1349.      Pinto MJ.  Pereira NF.  Rodrigues S.  Kharangate NV.  Verenkar MP. Rapid diagnosis of falciparum malaria by detection of Plasmodium falciparum HRP-2 antigen. Journal of the Association of Physicians of India.  47(11):1076-8, 1999  Nov.

 1350.      Prasad K.  Garner P. Steroids for treating cerebral malaria. [Review] [2 refs] Cochrane Database of Systematic Reviews [computer file].  (2):CD000972,  2000.

 1351.      Sharma P.  Swarup D.  Saxena GN.  Bhandari S.  Sharma UB.  Tuteja R. An open study to evaluate the efficacy of artemether in severe falciparum malaria. Journal of the Association of Physicians of India.  47(9):883-5, 1999 Sep.

 1352.      Siddiqi NJ.  Alhomida AS. Status of hepatic oxidative stress and antioxidant defense systems during chloroquine treatment of Plasmodium yoelii nigeriensis infected mice. In Vivo.  13(6):547-50, 1999 Nov-Dec.

 1353.      Smith HJ.  Meremikwu M. Iron chelating agents for treating malaria. [Review] [6 refs] Cochrane Database of Systematic Reviews [computer file].  (2):CD001474,  2000.

 1354.      Surolia N. Receptor-mediated targeting of toxins to intraerythrocytic parasite Plasmodium falciparum. [Review] [48 refs] Advanced Drug Delivery Reviews.  41(2):163-70, 2000 Mar 30.

 1355.      Warhurst DC. Drug resistance in Plasmodium falciparum malaria. [Review] [22 refs] Infection.  27 Suppl 2:S55-8, 1999.

 1356.      Winstanley PA. Chemotherapy for falciparum malaria: the armoury, the problems and the  prospects. [Review] [68 refs] Parasitology Today.  16(4):146-53, 2000 Apr.

 1357.      Woodrow CJ.  Riberio I.  Krishna S. Recent developments in the management of malaria. Indian Journal of Pediatrics.  66(1):103-9, 1999 Jan-Feb.

 1358.      Worley CW.  Worley KA.  Kumar PL. Infectious disease challenges in immigrants from tropical countries. Pediatrics.  106(1):E3, 2000 Jul.

 1359.      Yoshida S.  Kashiwamura SI.  Hosoya Y.  Luo E.  Matsuoka H.  Ishii A.  Fujimura A.  Kobayashi E. Direct immunization of malaria DNA vaccine into the liver by gene gun protects against lethal challenge of Plasmodium berghei sporozoite.Biochemical & Biophysical Research Communications.  271(1):107-15, 2000 Apr 29.

 1764. Amani V.  Vigario AM.  Belnoue E.  Marussig M.  Fonseca L.  Mazier D.  Renia  L. Involvement   of   IFN-gamma    receptor - medicated   signaling  in  pathology  and anti-malarial immunity induced by Plasmodium berghei infection. European Journal of Immunology.  30(6):1646-55, 2000 Jun.

 1765. Bartoloni  A.  Strohmeyer M.  Benucci M.  Sabatinelli G.  Paradisi F. ParaSight-F test for malaria diagnosis [letter; comment]. Transactions of the Royal Society of Tropical Medicine & Hygiene.   94(2):227-8, 2000 Mar-Apr.

 1766. Baruch DI. Adhesive receptors on malaria-parasitized red cells. [Review] [89 refs] Bailliere's Best Practice in Clinical Haematology.  12(4):747-61, 1999  Dec.

 1767. Berger BJ. Antimalarial activities of aminooxy compounds. Antimicrobial Agents & Chemotherapy.  44(9):2540-2, 2000 Sep.

 1768. Chen Q. Schlichtherle M. Wahlgren M. Molecular aspects of severe malaria. [Review] [132 refs]

 1769. Clinical Microbiology Reviews.  13(3):439-50, 2000 Jul.

 1770. Corral RS.  Petray PB. CpG DNA as a Th1-promoting adjuvant in immunization against Trypanosoma cruzi. Vaccine.  19(2-3):234-42, 2000 Sep 15.

 1771. Cropley IM.  Lockwood DN.  Mack D.  Pasvol G.  Davidson RN. Rapid diagnosis  of Falciparum malaria by using the ParaSight F test in  travellers returning to the United Kingdom: prospective study.  BMJ.  321(7259):484-5, 2000 Aug 19-26.

 1772. Dorsey G.   Gandhi M.  Oyugi JH.  Rosenthal PJ.  Difficulties  in  the  prevention, diagnosis, and treatment of imported  malaria. Archives of Internal Medicine.  160 (16): 2505-10, 2000 Sep 11.

 1773.  Dunyo SK. Afari EA. Koram KA.  Ahorlu CK.  Abubakar I.  Nkrumah FK. Health centre  versus  home  presumptive  diagnosis  of   malaria   in   southern   Ghana : implications  for  home-based  care  policy.  Transactions  of  the  Royal Society of Tropical Medicine & Hygiene.  94(3):285-8, 2000 May-Jun.

 1774. Gilberger TW. Schirmer RH. Walter RD. Muller S.  Deletion  of  the  parasite-spe-cific  insertions  and  mutation  of  the catalytic triad in glutathione reductase from chloroquine-sensitive  Plasmodium   falciparum  3D7.  Molecular  &  Biochemical Parasitology.  107(2):169-79, 2000 Apr 15.

 1775. Gogtay  NJ.  Desai  S.  Kadam  VS.  Kamtekar  KD.  Dalvi  SS.  Kshirsagar NA.  A randomized, parallel-group study in Mumbai (Bombay), comparing chloroquine with chloroquine plus sulfadoxine-pyrimethamine in the  treatment of adults with acute,  uncomplicated,  Plasmodium  falciparum   malaria.   Annals   of   Tropical Medicine & Parasitology.  94(4):309-12, 2000 Jun.

 1776. Gunaratne RS.  Sajid M.  Ling IT.  Tripathi R.  Pachebat JA.  Holder AA. Characterization of N-myristoyltransferase from Plasmodium falciparum. Biochemical  Journal.  348 Pt 2:459-63, 2000 Jun 1.

 1777. Hombhanje   FW.   In   vitro   susceptibility   of   Plasmodium   falciparum   to   four antimalarial drugs in the Central Province of Papua New Guinea. Papua New Guinea Medical Journal.  41(2):51-8, 1998 Jun.

 1778.  Homer MJ.  Aguilar-Delfin I.  Telford SR 3rd.  Krause PJ.  Persing DH. Babesiosis. [Review] [245 refs]Clinical Microbiology Reviews.  13(3):451-69, 2000 Jul.

 1779. Jelinek T.  Grobusch MP.  Nothdurft HD. Use  of  dipstick  tests  for  the rapid diagnosis of malaria in nonimmune  travelers. Journal of Travel Medicine.  7(4):175-9, 2000 Jul-Aug.

 1780.  Kidane G.  Morrow RH.  Teaching  mothers  to  provide home treatment of malaria in Tigray, Ethiopia: a randomised trial. Lancet.  356(9229):550-5, 2000 Aug 12.

 1781. Lauer  S. VanWye  J.  Harrison  T.  McManus  H. Samuel BU. Hiller NL. Mohandas N. Haldar  K. Vacuolar  uptake  of  host  components,  and  a  role  for  cholesterol  and sphingomyelin in malarial infection.EMBO Journal. 19(14):3556-64, 2000 Jul 17.

 1782. Lichtenthaler  HK.   Zeidler  J.   Schwender  J.   Muller  C.  The  non-mevalonate isoprenoid biosynthesis of plants as a test system  for  new  herbicides  and  drugs against pathogenic bacteria and the malaria  parasite. [Review] [39 refs] Zeitschrift fur Naturforschung.  Section  C.  Journal  of  Biosciences.  55 (5-6) : 305-13, 2000 May-Jun.

 1783.  Maneerat Y. Viriyavejakul P. Punpoowong B. Jones M. Wilairatana P.  Pongponratn E. Turner  GD.   Udomsangpetch  R.  Inducible  nitric  oxide  synthase  expression  is increased in the brain in fatal cerebral malaria. Histopathology.  37 ( 3 ) : 269-77, 2000 Sep.

 1784. Mirdha  BR.  Samantray  JC.  Mishra  B.   Xess  I .  Bone marrow examination for identifying  malaria  in  fever  of  unknown  origin.   Journal  of  the  Association  of Physicians of India.  47(2):177-9, 1999 Feb.

 1785. Mohanty S.  Mishra SK.  Mohanty A.  Das BS. Immunochromatographic test for the diagnosis of Falciparum malaria.  Journal of the Association of Physicians of India.  47(2):201-2, 1999 Feb.

 1786. Moody A.  Hunt-Cooke A.  Gabbett E.  Chiodini P. Performance of the OptiMAL malaria antigen capture dipstick for malaria diagnosis and treatment monitoring at the Hospital for Tropical Diseases, London.British Journal of Haematology.  109(4): 891-4, 2000 Jun.

 1787. Rahman NN. Evaluation of the sensitivity in vitro of Plasmodium falciparum and in  vivo of Plasmodium chabaudi Malaria to various drugs and their combinations. Medical Journal of Malaysia.  52(4):390-8, 1997 Dec.

 1788. Schlotmann T.  Waase I.  Julch C.  Klauenberg U.  Muller-Myhsok B.  Dietrich M.  Fleischer B.  Broker BM. CD4 alphabeta T lymphocytes express high levels of the T lymphocyte  antigen  CTLA-4  ( CD152 )  in acute malaria. Journal of Infectious Diseases.  182(1):367-70, 2000 Jul.

 1789.  Seder RA.  Hill  AV.   Vaccines  against  intracellular  infections  requiring  cellular immunity.  Nature.  406(6797):793-8, 2000 Aug 17.

 1790. Singh N.  Puri SK. Modulation of halofantrine resistance after coadministration of halofantrine with diverse pharmacological agents in a rodent malaria  model. Life Sciences.  67(11):1345-54, 2000 Aug 4.

 1791. Singh N.  Valecha N. Evaluation of a rapid diagnostic test, 'Determine malaria pf', in  epidemic-prone, forest villages of central India (Madhya Pradesh).  Annals of Tropical Medicine & Parasitology.  94(5):421-7, 2000 Jul.

 1792. Singhasivanon  P.  Mekong  malaria.  Malaria, multi-drug resistance and economic development in Smooker PM.  Setiady YY.  Rainczuk A.  Spithill TW. Expression library  immunization  protects  mice  against  a  challenge  with  virulent  rodent malaria.  Vaccine.  18(23):2533-40, 2000 May 22.

 1793. Srinivasan S.  Moody AH.  Chiodini PL.  Comparison  of  blood-film  microscopy, the   OptiMAL   dipstick,   Rhodamine-123   fluorescence   staining   and  PCR,  for monitoring  antimalarial  treatment.  Annals of  Tropical Medicine & Parasitology. 94(3):227-32, 2000 Apr.

 1794. Stephens  JK.  Phanart  K.  Rooney  W.  Barnish  G.  A comparison of three malaria diagnostic  tests, under  field  conditions in North-west Thailand.  Southeast Asian Journal of Tropical Medicine & Public Health.30(4):625-30, 1999 Dec.

 1795. Vrachliotis  TG.  Bennett  WF.  Vaswani  KK.  Niemann  TH.  Bova  JG.   Primary angiosarcoma of the spleen--CT, MR, and sonographic characteristics :  report  of two cases. Abdominal Imaging.  25(3):283-5, 2000 May-Jun.

 1796. Waterkeyn JG.  Wickham ME.  Davern KM.  Cooke BM.  Coppel RL.  Reeder JC. Culvenor  JG.   Waller  RF.   Cowman  AF.   Targeted  mutagenesis  of  Plasmodium falciparum erythrocyte membrane protein 3 (PfEMP3) disrupts cytoadherence of malaria-infected red blood cells. EMBO Journal.  19(12):2813-23, 2000 Jun 15.

 1797. Wickramasinghe  SN.  Abdalla  SH.  Blood  and  bone marrow changes in malaria. [Review] [96 refs] Bailliere's Best Practice in Clinical Haematology. 13(2) : 277-99, 2000 Jun.

2250.      Afzaal S.  Singh M.  Fatima S.  Koshy AA. Rapid diagnostic tests for malaria.  Journal of the Association of Physicians of India.  49:261-5, 2001 Feb.

2251.      Ambe JP.  Fatunde JO.  Sodeinde OO.  Associated morbidities in children with sickle-cell anaemia presenting with severe anaemia in a malarious area.  Tropical Doctor.  31(1):26-7, 2001 Jan.

2252.      Anand AC. Liver in malaria. [Review] [12 refs]  Indian Journal of Gastroenterology.  20 Suppl 1:C37-8, 2001 Mar.

2253.      Attaran  A. Global health agencies' response to malaria. Panel should be set up to review malaria control proposals from endemic countries. BMJ.  322(7279):174; discussion 174-5, 2001 Jan 20.

2254.      Aucan C.  Traore Y.  Fumoux F.  Rihet P.  Familial correlation of immunoglobulin G subclass responses to Plasmodium falciparum antigens in Burkina Faso. Infection & Immunity.  69(2):996-1001, 2001 Feb.

2255.      Bailo Diallo A.  De Serres G.  Beavogui AH.  Lapointe C.  Viens P.  Home care of malaria-infected children of less than 5 years of age in a rural area of the Republic of Guinea.  Bulletin of the World Health Organization.  79(1):28-32, 2001.

2256.      Bannister LH. Looking for the exit: How do malaria parasites escape from red blood cells?. Proceedings of the National Academy of Sciences of the United States of America.  98(2):383-4, 2001 Jan 16.

2257.      Bates I.  Bedu-Addo G.  Jarrett RF.  Schulz T.  Wallace S.  Armstrong A.  Sheldon J.  Rutherford T. B-lymphotropic viruses in a novel tropical splenic lymphoma. British Journal of Haematology.  112(1):161-6, 2001 Jan.

2258.      Beeson JG.  Winstanley PA.  McFadden GI.  Brown GV. New agents to combat malaria. [letter; comment].  Nature Medicine.  7(2):149-50, 2001 Feb.

2259.      Ben Mamoun C.  Gluzman IY.  Hott C.  MacMillan SK.  Amarakone AS.  Anderson DL.  Carlton JM.  Dame JB.  Chakrabarti D.  Martin RK.  Brownstein BH.  Goldberg DE. Co-ordinated programme of gene expression during asexual intraerythrocytic development of the human malaria parasite Plasmodium falciparum revealed by microarray analysis.  Molecular Microbiology.  39(1):26-36, 2001 Jan.

2260.      Brabin BJ.  Hakimi M.  Pelletier D. An analysis of anemia and pregnancy-related maternal mortality. [Review] [90 refs]  Journal of Nutrition.  131(2S-2):604S-614S; discussion 614S-615S, 2001 Feb.

2261.      Brieger WR. Are people in rural African communities willing to pay for the re-treatment of insecticide-impregnated nets (ITNs)?. Tropical Medicine & International Health.  6(1):85-6, 2001 Jan. 

2262.      Buchovsky AS.  Campetella O.  Russomando G.  Franco L.  Oddone R.  Candia N.  Luquetti A.  Gonzalez Cappa SM.  Leguizamon MS. trans-sialidase inhibition assay, a highly sensitive and specific diagnostic test for Chagas' disease. Clinical & Diagnostic Laboratory Immunology.  8(1):187-9, 2001 Jan.

2263.      Cahill JD. The febrile traveler. Medicine & Health, Rhode Island.  84(1):16-8, 2001 Jan.

2264.      Capron A.  Capron M.  Dombrowicz D.  Riveau G. Vaccine strategies against schistosomiasis: from concepts to clinical trials.  International Archives of Allergy & Immunology.  124(1-3):9-15, 2001 Jan-Mar.

2265.      Cavanagh DR.  Dobano C.  Elhassan IM.  Marsh K.  Elhassan A.  Hviid L.  Khalil EA.  Theander TG.  Arnot DE.  McBride JS. Differential patterns of human immunoglobulin G subclass responses to distinct regions of a single protein, the merozoite surface protein 1 of Plasmodium falciparum.  Infection & Immunity.  69(2):1207-11, 2001 Feb.

2266.      Chitnis CE.  Molecular insights into receptors used by malaria parasites for erythrocyte invasion. [Review] [75 refs]  Current Opinion in Hematology.  8(2):85-91, 2001 Mar.

2267.      Curtis CF.  Insecticide resistance and mosquito-borne disease. Lancet.  357(9257):656, 2001 Mar 3.

2268.      Deitsch K.  Driskill C.  Wellems T. Transformation of malaria parasites by the spontaneous uptake and expression of DNA from human erythrocytes. Nucleic Acids Research.  29(3):850-3, 2001 Feb 1.

2269.      Desai DC.  Gupta T.  Sirsat RA.  Shete M. Malarial pancreatitis: report of two cases and review of the literature. [Review] [7 refs] American Journal of Gastroenterology.  96(3):930-2, 2001 Mar.

2270.      Dimopoulos G.  Muller HM.  Levashina EA.  Kafatos FC.  Innate immune defense against malaria infection in the mosquito. [Review] [72 refs]  Current Opinion in Immunology.  13(1):79-88, 2001 Feb.

2271.      Djimde A.  Doumbo OK.  Cortese JF.  Kayentao K.  Doumbo S.  Diourte Y.  Dicko A.  Su XZ.  Nomura T.  Fidock DA.  Wellems TE.  Plowe CV.  Coulibaly D.  A molecular marker for chloroquine-resistant falciparum malaria. [see comments].  New England Journal of Medicine.  344(4):257-63, 2001 Jan 25.

2272.      Etchegorry MG.  Matthys F.  Galinski M.  White NJ.  Nosten F.  Malaria epidemic in Burundi. Lancet.  357(9261):1046-7, 2001 Mar 31.

2273.      Fang CT.  Chang HL.  Hsieh WC.  Malaria eradication on islands. Lancet.  357(9255):560, 2001 Feb 17.

2274.      Franks S.  Koram KA.  Wagner GE.  Tetteh K.  McGuinness D.  Wheeler JG.  Nkrumah F.  Ranford-Cartwright L.  Riley EM. Frequent and persistent, asymptomatic Plasmodium falciparum infections in African infants, characterized by multilocus genotyping.   Journal of Infectious Diseases.  183(5):796-804, 2001 Mar 1.

2275.      Gautret P.  Legros F.  Koulmann P.  Rodier MH.  Jacquemin JL. Imported Plasmodium vivax malaria in France: geographical origin and report of an atypical case acquired in Central or Western Africa.  Acta Tropica.  78(2):177-81, 2001 Feb 23.

2276.      Gautret P.  Plasmodium falciparum gametocyte periodicity. Acta Tropica.  78(1):1-2, 2001 Jan 15.

2277.      Ghosh K.  Javeri KN.  Mohanty D.  Parmar BD.  Surati RR.  Joshi SH.  False-positive serological tests in acute malaria.  British Journal of Biomedical Science.  58(1):20-3, 2001.

2278.      James AA. Present and future control of malaria.  Science.  291(5503):435-6, 2001 Jan 19.

2279.      Jouin H.  Rogier C.  Trape JF.  Mercereau-Puijalon O.  Fixed, epitope-specific, cytophilic antibody response to the polymorphic block 2 domain of the Plasmodium falciparum merozoite surface antigen MSP-1 in humans living in a malaria-endemic area.  European Journal of Immunology.  31(2):539-50, 2001 Feb.

2280.      Kamat VR.  Private practitioners and their role in the resurgence of malaria in Mumbai (Bombay) and Navi Mumbai (New Bombay), India: serving the affected or aiding an epidemic?. Social Science & Medicine.  52(6):885-909, 2001 Mar.

2281.      Kramer MH.  Lobel HO. Antimalarial chemoprophylaxis in infants and children. [Review] [58 refs]  Paediatric Drugs.  3(2):113-21, 2001.

2282.      Kristiansen M.  Graversen JH.  Jacobsen C.  Sonne O.  Hoffman HJ.  Law SK.  Moestrup SK. Identification of the haemoglobin scavenger receptor. [see comments]. Nature.  409(6817):198-201, 2001 Jan 11.

2283.      Lee CS.  Salcedo E.  Wang Q.  Wang P.  Sims PF.  Hyde JE. Characterization of three genes encoding enzymes of the folate biosynthetic pathway in Plasmodium falciparum.  Parasitology.  122 Pt 1:1-13, 2001 Jan.

2284.      Lee HK.  Lim J.  Kim M.  Lee S.  Oh EJ.  Lee J.  Oh J.  Kim Y.  Han K.  Lee EJ.  Kang CS.  Kim BK.  Immunological alterations associated with Plasmodium vivax malaria in South Korea. Annals of Tropical Medicine & Parasitology.  95(1):31-9, 2001 Jan.

2285.      Lengeler C.  Comparison of malaria control interventions.  Bulletin of the World Health Organization.  79(1):77, 2001.

2286.      Letvin NL.  Bloom BR.  Hoffman SL. Prospects for vaccines to protect against AIDS, tuberculosis, and malaria. JAMA.  285(5):606-11, 2001 Feb 7.

2287.      May J.  Lell B.  Luty AJ.  Meyer CG.  Kremsner PG. HLA-DQB1*0501-restricted Th1 type immune responses to Plasmodium falciparum liver stage antigen 1 protect against malaria anemia and reinfections.  Journal of Infectious Diseases.  183(1):168-72, 2001 Jan 1.

2288.      McCarthy M.  Should visits to relatives carry a health warning?.  Lancet.  357(9259):862, 2001 Mar 17.

2289.      Menan H.  Dakoury-Dogbo N.  Rouet F.  Huet C.  Anglaret X.  Cotrimo-CI study group.  HIV-1 infection and malaria parasitaemia.  Lancet.  357(9251):233, 2001 Jan 20.

2290.      Miao WM.  Vasile E.  Lane WS.  Lawler J. CD36 associates with CD9 and integrins on human blood platelets. Blood.  97(6):1689-96, 2001 Mar 15.

2291.      Migot-Nabias F.  Luty AJ.  Minh TN.  Fajardy I.  Tamouza R.  Marzais F.  Charron D.  Danze PM.  Renaut A.  Deloron P. HLA alleles in relation to specific immunity to liver stage antigen-1 from plasmodium falciparum in Gabon. Genes & Immunity.  2(1):4-10, 2001 Feb.

2292.      Mockenhaupt FP.  May J.  Bergqvist Y.  Meyer CG.  Falusi AG.  Bienzle U. Evidence for a reduced effect of chloroquine against Plasmodium falciparum in alpha-thalassaemic children.  Tropical Medicine & International Health.  6(2):102-7, 2001 Feb.

2293.      Nabarro D.  Roberfroid A.  Pannenborg O.  Global health agencies' response to malaria. Agencies dispute Attaran's view of Roll Back Malaria initiative.  BMJ.  322(7279):174-5, 2001 Jan 20.

2294.      Nacher M. Singhasivanon P. Vannaphan S.  Treeprasertsuk S.  Phanumaphorn M.  Traore B.  Looareesuwan S.  Gay F.  Socio-economic and environmental protective/risk factors for severe malaria in Thailand. Acta Tropica.  78(2):139-46, 2001 Feb 23.

2295.      Nardin EH.  Calvo-Calle JM.  Oliveira GA.  Nussenzweig RS.  Schneider M.  Tiercy JM.  Loutan L.  Hochstrasser D.  Rose K. A totally synthetic polyoxime malaria vaccine containing Plasmodium falciparum B cell and universal T cell epitopes elicits immune responses in volunteers of diverse HLA types.  Journal of Immunology.  166(1):481-9, 2001 Jan 1.

2296.      Ndounga M.  Basco LK.  Ringwald P.  Evaluation of a new sulfadoxine sensitivity assay in vitro for field isolates of Plasmodium falciparum.  Transactions of the Royal Society of Tropical Medicine & Hygiene.  95(1):55-7, 2001 Jan-Feb.

2297.      Oliveira-Ferreira J.  Daniel-Ribeiro C.  Protective CD8+ T cell responses against the pre-erythrocytic stages of malaria parasites: an overview. [Review] [56 refs]  Memorias do Instituto Oswaldo Cruz.  96(2):221-7, 2001 Feb.

2298.      Park JW.  Moon SH.  Yeom JS.  Lim KJ.  Sohn MJ.  Jung WC.  Cho YJ.  Jeon KW.  Ju W.  Ki CS.  Oh MD.  Choe K. Naturally acquired antibody responses to the C-terminal region of merozoite surface protein 1 of Plasmodium vivax in Korea.  Clinical & Diagnostic Laboratory Immunology.  8(1):14-20, 2001 Jan.

2299.      Parola P.  Ranque S.  Badiaga S.  Niang M.  Blin O.  Charbit JJ.  Delmont J.  Brouqui P.  Controlled trial of 3-day quinine-clindamycin treatment versus 7-day quinine treatment for adult travelers with uncomplicated falciparum malaria imported from the tropics.  Antimicrobial Agents & Chemotherapy.  45(3):932-5, 2001 Mar.

2300.      Perkins DJ.  Kremsner PG.  Weinberg JB. Inverse relationship of plasma prostaglandin E2 and blood mononuclear cell cyclooxygenase-2 with disease severity in children with Plasmodium falciparum malaria. Journal of Infectious Diseases.  183(1):113-8, 2001 Jan 1.

2301.      Pillai DR.  Labbe AC.  Vanisaveth V.  Hongvangthong B.  Pomphida S.  Inkathone S.  Zhong K.  Kain KC.  Plasmodium falciparum malaria in Laos: chloroquine treatment outcome and predictive value of molecular markers.  Journal of Infectious Diseases.  183(5):789-95, 2001 Mar 1.

2302.      Proux S.  Hkirijareon L.  Ngamngonkiri C.  McConnell S.  Nosten F. Paracheck-Pf: a new, inexpensive and reliable rapid test for P. falciparum malaria.  Tropical Medicine & International Health.  6(2):99-101, 2001 Feb.

2303.      Salmon BL.  Oksman A.  Goldberg DE. Malaria parasite exit from the host erythrocyte: a two-step process requiring extraerythrocytic proteolysis.  Proceedings of the National Academy of Sciences of the United States of America.  98(1):271-6, 2001 Jan 2.

2304.      Schluesener HJ.  Kremsner PG.  Meyermann R. Heme oxygenase-1 in lesions of human cerebral malaria. Acta Neuropathologica.  101(1):65-8, 2001 Jan.

2305.      Sharma P.  Sharma JD.  A review of plant species assessed in vitro for antiamoebic activity or both antiamoebic and antiplasmodial properties. [Review] [60 refs]  Phytotherapy Research.  15(1):1-17, 2001 Feb.

2306.      Sowunmi A.  Adedeji AA.  Sowunmi CO.  Falade CO.  Falade AG.  Ohaeri B.  Happi TC.  Oduola AM. Clinical characteristics and disposition kinetics of the hepatomegaly associated with acute, uncomplicated, Plasmodium falciparum malaria in children.  Annals of Tropical Medicine & Parasitology.  95(1):7-18, 2001 Jan.

2307.      Stevenson MM.  Su Z.  Sam H.  Mohan K. Modulation of host responses to blood-stage malaria by interleukin-12: from therapy to adjuvant activity. [Review] [77 refs]  Microbes & Infection.  3(1):49-59, 2001 Jan.

2308.      Thellier M.  Lusina D.  Guiguen C.  Delamaire M.  Legros F.  Ciceron L.  Klerlein M.  Danis M.  Mazier D. Is airport malaria a transfusion-transmitted malaria risk?. Transfusion.  41(2):301-2, 2001 Feb.

2309.      Tkachuk AN.  Moormann AM.  Poore JA.  Rochford RA.  Chensue SW.  Mwapasa V.  Meshnick SR. Malaria enhances expression of CC chemokine receptor 5 on placental macrophages. Journal of Infectious Diseases.  183(6):967-72, 2001 Mar 15.

2310.      Van den Ende J.  Morales I.  Van den Abbeele K.  Clerinx J.  Colebunders R.  Kager P.  Lynen L.  Van Gompel A.  Van der Planken M.  Vervoort T. Changing epidemiological and clinical aspects of imported malaria in Belgium.  Journal of Travel Medicine.  8(1):19-25, 2001 Jan-Feb.

2311.      van Wendel de Joode B.  Wesseling C.  Kromhout H.  Monge P.  Garcia M.  Mergler D. Chronic nervous-system effects of long-term occupational exposure to DDT. Lancet.  357(9261):1014-6, 2001 Mar 31.

2312.      Verhoef H.  Veenemans J.  West CE. HIV-1 infection and malaria parasitaemia.  Lancet.  357(9251):232-3, 2001 Jan 20.

2313.      Wabwire-Mangen F.  Gray RH.  Wawer MJ.  Sewankambo N.  Serwadda D  HIV-1 infection and malaria parasitaemia.  Lancet.  357(9251):233, 2001 Jan 20.

2314.      Ward SA.  Bray PG.  Is reversal of chloroquine resistance ready for the clinic?.  Lancet.  357(9260):904, 2001 Mar 24.

2315.      Warhurst DC.  A molecular marker for chloroquine-resistant falciparum malaria. [letter; comment]. New England Journal of Medicine.  344(4):299-302, 2001 Jan 25.

2316.      Watanabe J.  Sasaki M.  Suzuki Y.  Sugano S.  FULL-malaria: a database for a full-length enriched cDNA library from human malaria parasite, Plasmodium falciparum. Nucleic Acids Research.  29(1):70-1, 2001 Jan 1.

2317.      Weisman S.  Wang L.  Billman-Jacobe H.  Nhan DH.  Richie TL.  Coppel RL. Antibody responses to infections with strains of Plasmodium falciparum expressing diverse forms of merozoite surface protein 2.  Infection & Immunity.  69(2):959-67, 2001 Feb.

2318.      Worku S.  Troye-Blomberg M.  Christensson B.  Bjorkman A.  Fehniger T.  Activation of T cells in the blood of patients with acute malaria: proliferative activity as indicated by Ki-67 expression.  Scandinavian Journal of Immunology.  53(3):296-301, 2001 Mar.

2319.      Yanze MF.  Duru C.  Jacob M.  Bastide JM.  Lankeuh M. Rapid therapeutic response onset of a new pharmaceutical form of chloroquine phosphate 300 mg: effervescent tablets. Tropical Medicine & International Health.  6(3):196-201, 2001 Mar.

2836.      Avila SL.  Goldberg AC.  Arruk VG.  Marin ML.  Guilherme L.  Kalil J.  Ferreira AW.  Immune responses to multiple antigen peptides containing T and B epitopes from Plasmodium falciparum circumsporozoite protein of Brazilian individuals naturally exposed to malaria. Parasite Immunology.  23(2):103-8, 2001 Feb.

2837.      Bashwari LA.  Mandil AM.  Bahnassy AA.  Al-Shamsi MA.  Bukhari HA. Epidemiological profile of malaria in a university hospital in the eastern region of Saudi Arabia.  Saudi Med J.  22(2):133-8, 2001 Feb.

2838.      Biswas S.  Karmarkar MG.  Sharma YD. Antibodies detected against Plasmodium falciparum haemozoin with inhibitory properties to cytokine production.  FEMS Microbiology Letters.  194(2):175-9, 2001 Jan 15.

2839.      Coleman MD. Dapsone-mediated agranulocytosis: risks, possible mechanisms and prevention. [Review] [51 refs]  Toxicology.  162(1):53-60, 2001 Apr 12.

2840.      Crispo A.  Tamburini M.  De Marco MR.  Ascierto P.  Silvestro P.  Ronga D.  Tridente V.  Desicato S.  Carbone S.  Fabbrocini G.  Spiteri D.  Montella M. HHV-8 prevalence, immunosuppression and Kaposi's sarcoma in South Italy.  International Journal of Molecular Medicine.  7(5):535-8, 2001 May.

2841.      Efferth T.  Dunstan H.  Sauerbrey A.  Miyachi H.  Chitambar CR. The anti-malarial artesunate is also active against cancer. International Journal of Oncology.  18(4):767-73, 2001 Apr.

2842.      Hensmann M.  Kwiatkowski D.  Cellular basis of early cytokine response to Plasmodium falciparum.  Infection & Immunity.  69(4):2364-71, 2001 Apr.

2843.      Hoffmann EH.  da Silveira LA.  Tonhosolo R.  Pereira FJ.  Ribeiro WL.  Tonon AP.  Kawamoto F.  Ferreira MU. Geographical patterns of allelic diversity in the Plasmodium falciparum malaria-vaccine candidate, merozoite surface protein-2. Annals of Tropical Medicine & Parasitology.  95(2):117-32, 2001 Mar.

2844.      Hviid L.  Kurtzhals JA.  Adabayeri V.  Loizon S.  Kemp K.  Goka BQ.  Lim A.  Mercereau-Puijalon O.  Akanmori BD.  Behr C. Perturbation and proinflammatory type activation of V delta 1(+) gamma delta T cells in African children with Plasmodium falciparum malaria. Infection & Immunity.  69(5):3190-6, 2001 May.

2845.      Kenyon G. GSK renews malaria efforts. GlaxoSmithKline Biologicals. Nature Medicine.  7(4):389, 2001 Apr.

2846.      Khattab A.  Kun J.  Deloron P.  Kremsner PG.  Klinkert MQ. Variants of Plasmodium falciparum erythrocyte membrane protein 1 expressed by different placental parasites are closely related and adhere to chondroitin sulfate A.  Journal of Infectious Diseases.  183(7):1165-9, 2001 Apr 1.

2847.      Lal AA.  Patterson PS.  Sacci JB.  Vaughan JA.  Paul C.  Collins WE.  Wirtz RA.  Azad AF. Anti-mosquito midgut antibodies block development of Plasmodium falciparum and Plasmodium vivax in multiple species of Anopheles mosquitoes and reduce vector fecundity and survivorship.  Proceedings of the National Academy of Sciences of the United States of America.  98(9):5228-33, 2001 Apr 24.

2848.      Magnussen P.  Ndawi B.  Sheshe AK.  Byskov J.  Mbwana K. Malaria diagnosis and treatment administered by teachers in primary schools in Tanzania.  Tropical Medicine & International Health.  6(4):273-9, 2001 Apr.

2849.      Muniz-Junqueira MI.  dos Santos-Neto LL.  Tosta CE. Influence of tumor necrosis factor-alpha on the ability of monocytes and lymphocytes to destroy intraerythrocytic Plasmodium falciparum in vitro. Cellular Immunology.  208(2):73-9, 2001 Mar 15.

2850.      Nuwaha F. The challenge of chloroquine-resistant malaria in sub-Saharan Africa. [Review] [127 refs] Health Policy & Planning.  16(1):1-12, 2001 Mar.

2851.      Ockenhouse CF.  Barbosa A.  Blackall DP.  Murphy CI.  Kashala O.  Dutta S.  Lanar DE.  Daugherty JR. Sialic acid-dependent binding of baculovirus-expressed recombinant antigens from Plasmodium falciparum EBA-175 to Glycophorin A.  Molecular & Biochemical Parasitology.  113(1):9-21, 2001 Mar.

2852.      Ohnishi K.  Kimura K.  Serum levels of vascular cell adhesion molecule 1 in the early post-treatment defervescent phase of falciparum malaria.  Parasitology Research.  87(1):67-9, 2001 Jan.

2853.      Phillips RS. Current status of malaria and potential for control. [Review] [212 refs] Clinical Microbiology Reviews.  14(1):208-26, 2001 Jan.

2854.      Schellenberg D.  Menendez C.  Kahigwa E.  Aponte J.  Vidal J.  Tanner M.  Mshinda H.  Alonso P. Intermittent treatment for malaria and anaemia control at time of routine vaccinations in Tanzanian infants: a randomised, placebo-controlled trial. Lancet.  357(9267):1471-7, 2001 May 12.

2855.      Stead AM.  Bray PG.  Edwards IG.  DeKoning HP.  Elford BC.  Stocks PA.  Ward SA.  Diamidine compounds: selective uptake and targeting in Plasmodium falciparum. Molecular Pharmacology.  59(5):1298-306, 2001 May.

2856.      Toteja R.  Nair L.  Bhasin V. Genome comparison of progressively drug resistant Plasmodium falciparum lines derived from drug sensitive clone.  Memorias do Instituto Oswaldo Cruz.  96(3):427-33, 2001 Apr.

2857.      Webster G.  Barnes E.  Dusheiko G.  Franklin I.  Protecting travellers from hepatitis A. BMJ.  322(7296):1194-5, 2001 May 19.


Click here for Abstract

Back To Content Page